Transcend Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.39M | Sell |
10,759
-7,279
| -40% | -$5.67M | 0.65% | 32 |
|
|
2025
Q1 | $14.9M | Buy |
18,038
+703
| +4% | +$581K | 1.07% | 14 |
|
|
2024
Q4 | $13.4M | Buy |
17,335
+797
| +5% | +$615K | 0.97% | 16 |
|
|
2024
Q3 | $14.7M | Sell |
16,538
-393
| -2% | -$348K | 0.98% | 16 |
|
|
2024
Q2 | $15.3M | Buy |
16,931
+1,518
| +10% | +$1.37M | 1.11% | 12 |
|
|
2024
Q1 | $12M | Buy |
15,413
+632
| +4% | +$492K | 0.96% | 16 |
|
|
2023
Q4 | $8.62M | Buy |
14,781
+336
| +2% | +$196K | 0.76% | 25 |
|
|
2023
Q3 | $7.76M | Sell |
14,445
-760
| -5% | -$408K | 0.76% | 26 |
|
|
2023
Q2 | $7.13M | Buy |
15,205
+344
| +2% | +$161K | 0.68% | 28 |
|
|
2023
Q1 | $5.1M | Buy |
14,861
+852
| +6% | +$293K | 0.53% | 37 |
|
|
2022
Q4 | $5.13M | Buy |
14,009
+548
| +4% | +$200K | 0.56% | 36 |
|
|
2022
Q3 | $4.35M | Sell |
13,461
-83
| -0.6% | -$26.8K | 0.48% | 42 |
|
|
2022
Q2 | $4.39M | Sell |
13,544
-51
| -0.4% | -$16.5K | 0.46% | 44 |
|
|
2022
Q1 | $3.89M | Sell |
13,595
-62
| -0.5% | -$17.8K | 0.35% | 67 |
|
|
2021
Q4 | $3.77M | Buy |
13,657
+318
| +2% | +$87.8K | 0.33% | 79 |
|
|
2021
Q3 | $3.31M | Buy |
13,339
+1,156
| +9% | +$287K | 0.3% | 87 |
|
|
2021
Q2 | $2.8M | Buy |
12,183
+5,192
| +74% | +$1.19M | 0.4% | 67 |
|
|
2021
Q1 | $1.3M | Sell |
6,991
-240
| -3% | -$44.7K | 0.16% | 145 |
|
|
2020
Q4 | $1.22M | Buy |
+7,231
| New | +$1.22M | 0.16% | 142 |
|